Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MRTX, XBI, SRPT, MRNA, BIIB, and represent 30.92% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: SRPT (+$89M), MRTX (+$73M), BIIB (+$68M), XBI (+$67M), MRNA (+$54M), IGMS (+$42M), NVAX (+$41M), CYTK (+$34M), HZNP (+$30M), CYRX (+$25M).
- Started 52 new stock positions in CMRX, HST, NVAX, KOD, BMY, HZNP, ARYBU, ABUS, MREO, ARPO.
- Reduced shares in these 10 stocks: SPY (-$167M), BPMC (-$57M), ARGX (-$33M), QQQ (-$31M), FXI (-$24M), CCXI (-$22M), XLRN (-$21M), VNQ (-$20M), ACC (-$19M), GBT (-$18M).
- Sold out of its positions in XLRN, Achieve Life Science, Aduro Biotech, AEZS, ALBO, ALLK, ACC, AXSM, BMRN, BPMC.
- Ikarian Capital was a net buyer of stock by $133M.
- Ikarian Capital has $1.4B in assets under management (AUM), dropping by 9.96%.
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital, LLC consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ikarian Capital
Companies in the Ikarian Capital portfolio as of the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mirati Therapeutics Put Option (MRTX) | 7.1 | $98M | +291% | 588k | 166.05 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 6.9 | $95M | +240% | 850k | 111.43 | |
| Sarepta Therapeutics Put Option (SRPT) | 6.4 | $89M | +24234% | 633k | 140.43 | |
| Moderna Put Option (MRNA) | 5.6 | $77M | +231% | 1.1M | 70.75 | |
| Biogen Idec (BIIB) | 5.0 | $69M | +30315% | 242k | 284.00 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 4.8 | $67M | -71% | 200k | 334.88 | |
| Igm Biosciences Put Option (IGMS) | 3.0 | $42M | NEW | 563k | 73.81 | |
| Novavax Com New Put Option (NVAX) | 3.0 | $41M | NEW | 378k | 108.35 | |
| Zymeworks Call Option (ZYME) | 2.5 | $35M | -18% | 745k | 46.58 | |
| Cytokinetics Com New (CYTK) | 2.4 | $34M | NEW | 1.5M | 21.64 | |
| Horizon Therapeutics Pub L SHS (HZNP) | 2.2 | $30M | NEW | 389k | 77.62 | |
| Cryoport Com Par $0.001 Put Option (CYRX) | 1.8 | $25M | NEW | 523k | 47.40 | |
| Seres Therapeutics Call Option (MCRB) | 1.8 | $24M | +42% | 858k | 28.31 | |
| Bristol Myers Squibb Call Option (BMY) | 1.7 | $24M | NEW | 400k | 60.29 | |
Setup an alertIkarian Capital will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Celldex Therapeutics Com New (CLDX) | 1.6 | $23M | -20% | 1.5M | 14.83 | |
| Incyte Corporation Put Option (INCY) | 1.6 | $22M | +62% | 250k | 89.74 | |
| Ascendis Pharma A/s Sponsored Adr Call Option (ASND) | 1.6 | $22M | 145k | 154.32 | ||
| Brainstorm Cell Therapeutics Com New Put Option (BCLI) | 1.4 | $20M | NEW | 1.2M | 16.92 | |
| Arena Pharmaceuticals Com New (ARNA) | 1.4 | $20M | +5200% | 265k | 74.60 | |
| Zogenix Com New Call Option (ZGNX) | 1.4 | $19M | 1.1M | 17.93 | ||
| Reata Pharmaceuticals Cl A Put Option (RETA) | 1.2 | $17M | -30% | 175k | 97.42 | |
| Fibrogen Call Option (FGEN) | 1.2 | $17M | +43% | 402k | 41.11 | |
| Madrigal Pharmaceuticals Call Option (MDGL) | 1.2 | $17M | +8% | 139k | 118.73 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $16M | +10% | 1.2M | 12.59 | |
| Intra Cellular Therapies Call Option (ITCI) | 1.1 | $15M | +26% | 591k | 25.66 | |
| Kodiak Sciences Put Option (KOD) | 1.1 | $15M | NEW | 250k | 59.21 | |
| Ocular Therapeutix (OCUL) | 0.9 | $13M | -16% | 1.7M | 7.61 | |
| Milestone Pharmaceuticals (MIST) | 0.9 | $13M | NEW | 1.7M | 7.32 | |
| Deciphera Pharmaceuticals Call Option (DCPH) | 0.9 | $12M | +140% | 240k | 51.31 | |
| Protara Therapeutics Com Stk (TARA) | 0.9 | $12M | +36% | 722k | 16.83 | |
| Sage Therapeutics (SAGE) | 0.9 | $12M | -54% | 196k | 61.12 | |
| Immunovant (IMVT) | 0.8 | $11M | +14% | 322k | 35.19 | |
| Aimmune Therapeutics Put Option (AIMT) | 0.8 | $11M | NEW | 327k | 34.45 | |
| Tracon Pharmaceuticals Com New (TCON) | 0.8 | $11M | NEW | 2.2M | 5.17 | |
| Scpharmaceuticals (SCPH) | 0.8 | $11M | 1.5M | 7.45 | ||
| Black Diamond Therapeutics (BDTX) | 0.8 | $11M | +102% | 359k | 30.23 | |
| Medical Properties Trust Put Option (MPW) | 0.8 | $11M | 600k | 17.63 | ||
| Crispr Therapeutics Namen Akt Put Option (CRSP) | 0.7 | $9.6M | -35% | 115k | 83.64 | |
| 89bio (ETNB) | 0.6 | $8.7M | NEW | 340k | 25.66 | |
| Gossamer Bio Call Option (GOSS) | 0.6 | $8.2M | -5% | 664k | 12.41 | |
| Ardelyx (ARDX) | 0.6 | $8.0M | +9% | 1.5M | 5.25 | |
| Alnylam Pharmaceuticals Put Option (ALNY) | 0.5 | $7.3M | NEW | 50k | 145.60 | |
| Adverum Biotechnologies Call Option (ADVM) | 0.5 | $7.2M | +46% | 698k | 10.30 | |
| Strongbridge Biopharma Shs Usd (SBBP) | 0.5 | $7.1M | +2% | 3.4M | 2.10 | |
| I Mab Sponsored Ads (IMAB) | 0.5 | $7.1M | NEW | 150k | 47.03 | |
| Chiasma (CHMA) | 0.5 | $7.0M | +13% | 1.6M | 4.30 | |
| Kura Oncology (KURA) | 0.5 | $6.9M | -63% | 226k | 30.47 | |
| Immatics SHS | 0.5 | $6.8M | NEW | 638k | 10.61 | |
| Clovis Oncology (CLVS) | 0.5 | $6.7M | +135% | 1.2M | 5.83 | |
| Bioxcel Therapeutics Call Option (BTAI) | 0.5 | $6.6M | -63% | 153k | 43.36 | |
| Arrowhead Pharmaceuticals Call Option (ARWR) | 0.5 | $6.5M | NEW | 150k | 43.06 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $6.4M | -36% | 156k | 41.24 | |
| Aerpio Pharmaceuticals (ARPO) | 0.4 | $5.9M | NEW | 3.9M | 1.50 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $5.9M | NEW | 190k | 30.77 | |
| Atara Biotherapeutics (ATRA) | 0.4 | $5.5M | NEW | 427k | 12.96 | |
| Chemocentryx Call Option (CCXI) | 0.4 | $5.5M | -79% | 100k | 54.80 | |
| Compass Pathways Sponsored Ads | 0.4 | $5.3M | NEW | 153k | 34.90 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.4 | $5.3M | +1113% | 343k | 15.32 | |
| X4 Pharmaceuticals (XFOR) | 0.4 | $4.9M | +14393% | 725k | 6.77 | |
| Sutro Biopharma (STRO) | 0.4 | $4.9M | NEW | 488k | 10.05 | |
| Lyra Therapeutics (LYRA) | 0.3 | $4.3M | NEW | 388k | 11.18 | |
| Host Hotels & Resorts Put Option (HST) | 0.3 | $4.3M | NEW | 400k | 10.79 | |
| Chardan Healthcr Acqstn 2 Unit 99/99/9999 (CHAQ.U) | 0.3 | $4.2M | 400k | 10.55 | ||
| Cara Therapeutics (CARA) | 0.3 | $4.2M | +13% | 332k | 12.73 | |
| Bristol-myers Squibb Right 99/99/9999 (BMY.R) | 0.3 | $4.1M | +63% | 1.8M | 2.25 | |
| Fate Therapeutics Put Option (FATE) | 0.3 | $4.0M | 100k | 39.98 | ||
| Agenus Com New (AGEN) | 0.3 | $3.8M | NEW | 950k | 4.00 | |
| Arvinas Ord Call Option (ARVN) | 0.3 | $3.8M | -38% | 160k | 23.61 | |
| Kadmon Hldgs (KDMN) | 0.3 | $3.7M | -4% | 937k | 3.92 | |
| Arya Sciences Acquistion Unit 06/09/2027 (ARYBU) | 0.3 | $3.5M | NEW | 318k | 11.00 | |
| Chimerix (CMRX) | 0.2 | $3.4M | NEW | 1.4M | 2.49 | |
| Kala Pharmaceuticals (KALA) | 0.2 | $3.4M | NEW | 452k | 7.50 | |
| Sierra Oncology Com New (SRRA) | 0.2 | $3.3M | +3150% | 314k | 10.67 | |
| Adicet Bio | 0.2 | $3.3M | NEW | 274k | 11.89 | |
| Eidos Therapeutics (EIDX) | 0.2 | $3.2M | -36% | 63k | 50.53 | |
| Lifesci Acquisition Corp (LSAC) | 0.2 | $3.0M | NEW | 242k | 12.40 | |
| Pandion Therapeutics | 0.2 | $3.0M | NEW | 260k | 11.45 | |
| Myovant Sciences Call Option (MYOV) | 0.2 | $2.8M | +669% | 200k | 14.05 | |
| Eiger Biopharmaceuticals (EIGR) | 0.2 | $2.8M | NEW | 340k | 8.14 | |
| Applied Genetic Technol Corp C (AGTC) | 0.2 | $2.7M | 546k | 4.86 | ||
| Proteostasis Therapeutics In (PTI) | 0.2 | $2.6M | NEW | 2.4M | 1.10 | |
| Assembly Biosciences (ASMB) | 0.2 | $2.6M | 158k | 16.44 | ||
| Harrow Health (HROW) | 0.2 | $2.6M | NEW | 459k | 5.59 | |
| Mustang Bio (MBIO) | 0.2 | $2.5M | +126% | 807k | 3.15 | |
| Nektar Therapeutics Call Option (NKTR) | 0.2 | $2.5M | 150k | 16.59 | ||
| Xenon Pharmaceuticals (XENE) | 0.2 | $2.5M | -25% | 223k | 11.07 | |
| Achieve Life Sciences | 0.2 | $2.4M | NEW | 284k | 8.37 | |
| Casi Pharmaceuticalsinc Com Stk (CASI) | 0.2 | $2.4M | +48% | 1.5M | 1.53 | |
| Cortexyme (CRTX) | 0.2 | $2.3M | NEW | 46k | 50.00 | |
| Bluebird Bio (BLUE) | 0.2 | $2.2M | -71% | 40k | 53.95 | |
| Poseida Therapeutics I | 0.1 | $2.0M | NEW | 228k | 8.87 | |
| Otonomy (OTIC) | 0.1 | $1.8M | -68% | 435k | 4.05 | |
| Nextcure (NXTC) | 0.1 | $1.8M | NEW | 200k | 8.80 | |
| Diamedica Therapeutics Com New (DMAC) | 0.1 | $1.8M | NEW | 415k | 4.24 | |
| Verastem (VSTM) | 0.1 | $1.7M | -26% | 1.4M | 1.21 | |
| Aptinyx (APTX) | 0.1 | $1.7M | -16% | 496k | 3.38 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.1 | $1.7M | -58% | 696k | 2.40 | |
| Avrobio Ord (AVRO) | 0.1 | $1.6M | NEW | 125k | 13.02 | |
| Solid Biosciences (SLDB) | 0.1 | $1.6M | 788k | 2.03 | ||
| Icad Com New (ICAD) | 0.1 | $1.6M | -41% | 181k | 8.80 | |
| Altimmune Com New (ALT) | 0.1 | $1.5M | -31% | 114k | 13.20 | |
| Aurinia Pharmaceuticals Call Option (AUPH) | 0.1 | $1.5M | -69% | 100k | 14.74 | |
| Immunomedics Call Option (IMMU) | 0.1 | $1.4M | 16k | 85.03 | ||
| Delcath Sys Com New (DCTH) | 0.1 | $1.1M | 94k | 11.62 | ||
| Axovant Gene The (AXGT) | 0.1 | $820k | -5% | 178k | 4.61 | |
| Vaxcyte (PCVX) | 0.1 | $796k | -88% | 16k | 49.41 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $784k | NEW | 50k | 15.68 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $738k | +991% | 50k | 14.76 | |
| Mereo Biopharma Group Ads (MREO) | 0.0 | $688k | NEW | 1.2M | 0.58 | |
| Rapt Therapeutics Put Option (RAPT) | 0.0 | $674k | NEW | 21k | 32.24 | |
| Inflarx Nv (IFRX) | 0.0 | $637k | 150k | 4.25 | ||
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.0 | $596k | 165k | 3.62 | ||
| Apellis Pharmaceuticals (APLS) | 0.0 | $565k | +780% | 19k | 30.17 | |
| Puma Biotechnology (PBYI) | 0.0 | $554k | 55k | 10.09 | ||
| Air Lease Corp Cl A Put Option (AL) | 0.0 | $518k | NEW | 18k | 29.43 | |
| Adma Biologics (ADMA) | 0.0 | $478k | -47% | 200k | 2.39 | |
| Cerecor (CERC) | 0.0 | $460k | -49% | 203k | 2.27 | |
| Corbus Pharmaceuticals Hldgs Call Option (CRBP) | 0.0 | $397k | -90% | 220k | 1.80 | |
| Arbutus Biopharma (ABUS) | 0.0 | $360k | NEW | 115k | 3.13 | |
| Dicerna Pharmaceuticals Put Option (DRNA) | 0.0 | $358k | -43% | 20k | 17.90 | |
| Epizyme (EPZM) | 0.0 | $347k | NEW | 29k | 11.93 | |
| Baudax Bio (BXRX) | 0.0 | $277k | 100k | 2.77 | ||
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.0 | $275k | -88% | 55k | 5.03 | |
| Bellus Health Com New (BLU) | 0.0 | $227k | NEW | 100k | 2.27 | |
| Millendo Therapeutics (MLND) | 0.0 | $220k | 135k | 1.63 | ||
| Tricida (TCDA) | 0.0 | $210k | -86% | 23k | 9.05 | |
| Argenx Se Sponsored Adr Put Option (ARGX) | 0.0 | $209k | -99% | 800.00 | 261.25 | |
| Inventiva Sa Ads | 0.0 | $177k | NEW | 15k | 11.80 | |
| Mesoblast Spons Adr Put Option (MESO) | 0.0 | $145k | NEW | 7.8k | 18.59 | |
| Global Blood Therapeutics In Put Option (GBT) | 0.0 | $117k | -99% | 2.1k | 55.71 | |
| Ovid Therapeutics Call Option (OVID) | 0.0 | $92k | NEW | 16k | 5.75 | |
| Precision Biosciences Ord (DTIL) | 0.0 | $55k | 8.8k | 6.24 | ||
| Stealth Biotherapeutics Corp Sponsored Ads (MITO) | 0.0 | $50k | 38k | 1.33 | ||
| Alpine Immune Sciences (ALPN) | 0.0 | $41k | 4.7k | 8.65 | ||
| Aptose Biosciences Com New (APTO) | 0.0 | $23k | NEW | 3.9k | 5.89 | |
| Alector (ALEC) | 0.0 | $3.0k | NEW | 321.00 | 9.35 | |
| Bctg Acquisition Corp | 0.0 | $2.0k | NEW | 250.00 | 8.00 | |
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2020 Q3 filed Nov. 16, 2020
- Ikarian Capital 2020 Q2 filed Aug. 14, 2020
- Ikarian Capital 2020 Q1 filed May 15, 2020
- Ikarian Capital 2019 Q4 filed Jan. 31, 2020